X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (709) 709
Conference Proceeding (37) 37
Publication (35) 35
Newspaper Article (17) 17
Patent (17) 17
Dissertation (8) 8
Book / eBook (7) 7
Magazine Article (6) 6
Book Chapter (4) 4
Report (2) 2
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (213) 213
male (146) 146
female (134) 134
middle aged (130) 130
adult (94) 94
aged (85) 85
index medicus (84) 84
cardiac & cardiovascular systems (50) 50
polymer science (47) 47
materials science, multidisciplinary (41) 41
physics, condensed matter (33) 33
time factors (33) 33
peripheral vascular disease (30) 30
animals (29) 29
treatment outcome (27) 27
risk factors (26) 26
follow-up studies (25) 25
adolescent (24) 24
aged, 80 and over (24) 24
analysis (24) 24
microbiology (23) 23
echocardiography (21) 21
risk (20) 20
surgery (20) 20
research (19) 19
disease (18) 18
atherosclerosis (17) 17
cardiology (17) 17
coronary artery disease (16) 16
chemistry, physical (15) 15
materials science (15) 15
medicine, general & internal (15) 15
cancer (14) 14
chemistry, multidisciplinary (14) 14
coronary angiography (14) 14
heart valve prosthesis (14) 14
bacteria (13) 13
case-control studies (13) 13
films (13) 13
hematology (13) 13
medicine & public health (13) 13
prognosis (13) 13
severity of illness index (13) 13
therapy (13) 13
ultrasonography (13) 13
angioplasty (12) 12
association (12) 12
conductivity (12) 12
management (12) 12
mice (12) 12
molecular sequence data (12) 12
physics, applied (12) 12
radiology, nuclear medicine & medical imaging (12) 12
stents (12) 12
identification (11) 11
medicine (11) 11
methods (11) 11
mortality (11) 11
poland (11) 11
raman spectroscopy (11) 11
veterinary sciences (11) 11
atomic force microscopy (10) 10
expression (10) 10
morphology (10) 10
nuclear science & technology (10) 10
organic superconductors (10) 10
permeability (10) 10
pharmacology & pharmacy (10) 10
predictive value of tests (10) 10
sensitivity and specificity (10) 10
thin-films (10) 10
urology & nephrology (10) 10
activation (9) 9
angiography (9) 9
article (9) 9
bacterial typing techniques (9) 9
bacteriology (9) 9
bistetrathiafulvalene (9) 9
coronary vessels (9) 9
economy (9) 9
fibrinolysis (9) 9
growth (9) 9
hemodynamics (9) 9
inflammation (9) 9
myocardial-infarction (9) 9
oncology (9) 9
research article (9) 9
risk assessment (9) 9
statins (9) 9
stenosis (9) 9
stroke (9) 9
survival (9) 9
x-ray diffraction (9) 9
age (8) 8
angioplasty, balloon, coronary (8) 8
c-reactive protein (8) 8
cardiovascular (8) 8
cardiovascular disease (8) 8
chemistry (8) 8
heart attacks (8) 8
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (708) 708
Polish (108) 108
French (8) 8
German (6) 6
Portuguese (3) 3
Chinese (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and on behalf of investigators of the national registry of ACS, Portugese Society of Cardiology and on behalf of EVITA-HF (Evidence Based Treatment - Heart Failure) and on behalf of ESTROFA and on behalf of Second Department of Internal Medicine and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of PRAGUE-2 and on behalf of German Diabetes and Dialysis Study Investigators and on behalf of Hull LifeLab and on behalf of on behalf of the DYDA Investigators and on behalf of OFICA study group and on behalf of BASKET-PROVE and on behalf of the Triple-Site versus Standard Resynchronization Therapy Study (TRUST CRT) Investigators and on behalf of Scripps Translational Science Institute and on behalf of OMEGA study group and on behalf of PL-ACS Invastigators and on behalf of German Aortic Valve Therapy Registry and on behalf of TO BELIEVERS and on behalf of PREDICTION Study Group and on behalf of The REACH registry investigators and on behalf of PL-ACS Investigators and on behalf of KNHI and on behalf of Emerging Concepts in Cardiovascular Medicine and on behalf of CHART-2 Investigators and on behalf of the Fushimi AF Registry investigators and on behalf of Brasilian Heart Study Group and on behalf of Taiwan acute coronary syndrome full spetrum registry study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 339 - 653
Journal Article
by Fox, K.M and Bertrand, M and Ferrari, R and Remme, W.J and Simoons, M.L and Simoons, M and Bassand, J.P and Aldershvile, J and Hildebrandt, P and Cokkinos, D and Toutouzas, P and Eha, J and Erhardt, L and Erikssen, J and Grybauskas, P and Kalnins, U and Karsch, K and Sechtem, U and Keltai, M and Klein, W and Lüscher, T and Mulcahy, D and Nieminen, M and Oto, A and Ozsaruhan, O and Paulus, W and Providencia, L and Riecansky, I and Ruzyllo, W and Santini, U and Tavazzi, L and Soler-Soler, J and Widimsky, P and Julian, D and Dargie, H and Murray, G and Kübler, W and Thygesen, K and Duprez, D and Steg, G and Drexel, H and Gombotz, G and Duprez, D and Heyndrickx, G.H and Legrand, V and Materne, P and Van Mieghem, W and Bocek, P and Branny, M and Cech, M and Charouzek, J and Drazka, J and Fabik, L and Florian, J and Francek, L and Groch, L and Havranek, P and Hradec, J and Jansky, P and Jirmar, R and Jokl, I and Krejcova, H and Kvasnak, M and Maratka, T and Marcinek, G and Moravcova, J and Nedbal, P and Peterka, K and Povolny, J and Rosolova, H and Semrad, B and Sochor, K and Spacek, R and Spinar, J and Stipal, R and Stuchlik, K and Sulda, M and Ulman, J and Vaclavicek, A and Vojtisek, P and Bjerregaard-Andersen, H and Hildebrandt, P and Kristensen, K and Madsen, J.K and Markenvard, J and Meibom, J and Norgaard, A and Scheibel, M and Eha, J and Leht, A and Teesalu, R and Vahula, V and Itkonen, A and Juvonen, J and Karmakoski, J and Kilkki, E and Koskela, E and Melin, J and Nieminen, M.S and Savola, R and ... and The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators and EURopean Trial Reduction Cardiac E and EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
The Lancet, ISSN 0140-6736, 09/2003, Volume 362, Issue 9386, pp. 782 - 788
Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | ACE | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | HYPERTENSION | EXPRESSION | CONVERTING-ENZYME-INHIBITORS | BLOOD-PRESSURE | CAPTOPRIL | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Cause of Death | Coronary Disease - mortality | Heart Failure - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Heart Arrest - prevention & control | Cardiovascular Diseases - mortality | Coronary Disease - drug therapy | Female | Myocardial Infarction - prevention & control | Perindopril - therapeutic use | Evaluation | Drug therapy | ACE inhibitors | Coronary heart disease | Cardiovascular agents | Cardiovascular disease | Heart attacks | Medical treatment | Morbidity | Clinical outcomes | Myocardial infarction | Risk | Evidence-based medicine | Subgroups | Reduction | Motivation | Peptidyl-dipeptidase A | Gangrene | Cardiology | Heart diseases | Heart failure | Hypertension | Stroke | Risk groups | Mortality | Coronary artery | Health risks | Risk reduction | Angina pectoris | Coronary artery disease | Disease control | Patients | Heart rate | Inhibitors | Coronary vessels | Angiotensin | Infarction | Diabetes | Ventricle | Cardiovascular diseases | Health risk assessment | Potassium
Journal Article
by Armstrong, Paul W and Bett, N and Brieger, D and Chew, D and Dick, R and Farshid, A and Garrahy, P and Gunalingham, B and Hendriks, R and Horowitz, J and Jepson, N and Lefkovits, J and Lo, S and Meredith, I and Nelson, G and New, G and Prasan, A and Rankin, J and Thompson, P and Worthley, S and Yadav, R and Huber, K and Maurer, G and Siostrzonek, P and Boland, J and Covens, C and Desmet, W and Dujardin, K and Vrolix, M and Buller, C and Klinke, P and Lazzam, C and Lutchmedial, S and Madan, M and Natarajan, M and Reeves, F and Rodes Cabau, J and Rose, B and Schampaert, E and Theroux, P and Traboulsi, M and Webb, J and Welsh, R and Zimmerman, R and Aschermann, M and Branny, M and Budesinsky, T and Cervinka, P and Frantisek, H and Frantisek, T and Groch, L and Kala, P and Ritcher, M and Rokyta, R and St'asek, J and Stipal, R and Varvarovsky, I and Zamanek, D and Zelizko, M and Toftegaard Nielsen, T and Rasmussen, K and RiisHansen, P and Thayssen, P and Beaufils, P and Geslin, P and Gottwalles, Y and Lebreton, H and LeMarec, H and Montalescot, G and Roul, G and Steg, P.G and Tronc, C and Berger, H.J and Borggrefe, M and Brachmann, J and Braun, P and Buerke, M and Figulla, H.R and Guelker, H and Hasenfuss, G and Heitzer, T and Heuer, H and Hoffman, E and Hoffmann, S and Kuck, K.H and Neumann, F.J and Neuzner, J and Rau, M and Richardt, G and Schunkert, H and Stern, R and Von Schedit, W and Werner, P.C and Zahn, R and Binetti, G and Bramucci, E and Carosio, G and Manari, A and Marzocchi, A and Medda, M and ... and APEX AMI Investigators
JAMA, ISSN 0098-7484, 01/2007, Volume 297, Issue 1, pp. 43 - 51
Journal Article